» Articles » PMID: 22275344

Combined IStent Trabecular Micro-bypass Stent Implantation and Phacoemulsification for Coexistent Open-angle Glaucoma and Cataract: a Long-term Study

Overview
Journal Br J Ophthalmol
Specialty Ophthalmology
Date 2012 Jan 26
PMID 22275344
Citations 78
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: To evaluate the long-term efficacy and safety of combined cataract surgery and Glaukos iStent implantation for coexistent open-angle glaucoma and cataract.

Methods: Prospective, non-comparative, uncontrolled, non-randomised, interventional case series study. Subjects older than 18 years with coexistent uncontrolled mild or moderate open-angle glaucoma (including pseudoexfoliative and pigmentary) and cataract underwent phacoemulsification and intraocular lens implantation along with ab-interno gonioscopically guided implantation of one Glaukos iStent. The variables recorded during a minimum of 3 years of follow-up were: intraocular pressure (IOP), number of antiglaucoma medications and best-corrected visual acuity.

Results: The 19 patients enrolled were 58-88 years old (mean age 74.6±8.44 years). Mean follow-up was 53.68±9.26 months. Mean IOP was reduced from 19.42±1.89 mm Hg to 16.26±4.23 mm Hg (p=0.002) at the end of follow up, indicating a 16.33% decrease in IOP. The mean number of pressure-lowering medications used by the patients fell from 1.32±0.48 to 0.84±0.89 (p=0.046). In 42% of patients, no antiglaucoma medications were used at the end of follow-up. Mean best-corrected visual acuity significantly improved from 0.29±0.13 to 0.62±0.3 (p<0.001). No complications of surgery were observed.

Conclusion: Combined cataract surgery and Glaukos iStent implantation seems to be an effective and safe procedure to treat coexistent open-angle glaucoma and cataract.

Citing Articles

Minimally invasive bleb surgery versus minimally invasive glaucoma surgery: a 12-month retrospective study.

Konopinska J, Golaszewska K, Saeed E Sci Rep. 2024; 14(1):12850.

PMID: 38834618 PMC: 11150400. DOI: 10.1038/s41598-024-61811-y.


Endocyclophotocoagulation Combined with Phacoemulsification in Glaucoma Treatment: Five-Year Results.

Bolek B, Wylegala A, Rebkowska-Juraszek M, Wylegala E Biomedicines. 2024; 12(1).

PMID: 38255291 PMC: 10813537. DOI: 10.3390/biomedicines12010186.


The effectiveness and safety of one-stage iStent-based micro-invasive glaucoma surgery-A retrospective study.

Hajduga-Szewczyk M, Smedowski A, Filipecka I, Mrukwa-Kominek E Front Med (Lausanne). 2023; 10:1273889.

PMID: 38076245 PMC: 10701898. DOI: 10.3389/fmed.2023.1273889.


Minimally Invasive Glaucoma Surgery: A Review of the Literature.

Balas M, Mathew D Vision (Basel). 2023; 7(3).

PMID: 37606500 PMC: 10443347. DOI: 10.3390/vision7030054.


The PreserFlo MicroShunt in the Context of Minimally Invasive Glaucoma Surgery: A Narrative Review.

Saeed E, Golaszewska K, Dmuchowska D, Zalewska R, Konopinska J Int J Environ Res Public Health. 2023; 20(4).

PMID: 36833599 PMC: 9957246. DOI: 10.3390/ijerph20042904.